Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 9846 | 1051 | 35.3 | 56% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 554 | 13833 | CEREBRAL ISCHEMIA//SPREADING DEPRESSION//ISCHEMIC TOLERANCE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | NIMODIPINE | Author keyword | 12 | 12% | 9% | 98 |
| 2 | EMOPAMIL | Author keyword | 4 | 67% | 0% | 4 |
| 3 | TC 81 | Author keyword | 4 | 67% | 0% | 4 |
| 4 | KB 2796 | Author keyword | 4 | 75% | 0% | 3 |
| 5 | LIFARIZINE | Author keyword | 3 | 50% | 0% | 4 |
| 6 | CD 349 | Author keyword | 3 | 60% | 0% | 3 |
| 7 | LEVEMOPAMIL | Author keyword | 3 | 60% | 0% | 3 |
| 8 | RS 87476 | Author keyword | 2 | 67% | 0% | 2 |
| 9 | CALCIUM ENTRY BLOCKER | Author keyword | 2 | 24% | 1% | 7 |
| 10 | LOMERIZINE | Author keyword | 2 | 27% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | NIMODIPINE | 12 | 12% | 9% | 98 | Search NIMODIPINE | Search NIMODIPINE |
| 2 | EMOPAMIL | 4 | 67% | 0% | 4 | Search EMOPAMIL | Search EMOPAMIL |
| 3 | TC 81 | 4 | 67% | 0% | 4 | Search TC+81 | Search TC+81 |
| 4 | KB 2796 | 4 | 75% | 0% | 3 | Search KB+2796 | Search KB+2796 |
| 5 | LIFARIZINE | 3 | 50% | 0% | 4 | Search LIFARIZINE | Search LIFARIZINE |
| 6 | CD 349 | 3 | 60% | 0% | 3 | Search CD+349 | Search CD+349 |
| 7 | LEVEMOPAMIL | 3 | 60% | 0% | 3 | Search LEVEMOPAMIL | Search LEVEMOPAMIL |
| 8 | RS 87476 | 2 | 67% | 0% | 2 | Search RS+87476 | Search RS+87476 |
| 9 | CALCIUM ENTRY BLOCKER | 2 | 24% | 1% | 7 | Search CALCIUM+ENTRY+BLOCKER | Search CALCIUM+ENTRY+BLOCKER |
| 10 | LOMERIZINE | 2 | 27% | 1% | 6 | Search LOMERIZINE | Search LOMERIZINE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | EMOPAMIL | 12 | 86% | 1% | 6 |
| 2 | HISTOLOGIC DAMAGE | 11 | 100% | 1% | 6 |
| 3 | KB 2796 | 11 | 78% | 1% | 7 |
| 4 | NIMODIPINE | 10 | 11% | 8% | 89 |
| 5 | CALCIUM ANTAGONIST NIMODIPINE | 10 | 46% | 2% | 16 |
| 6 | POSTISCHEMIC ENERGY METABOLISM | 6 | 100% | 0% | 4 |
| 7 | S EMOPAMIL | 5 | 60% | 1% | 6 |
| 8 | ENTRY BLOCKER | 5 | 31% | 1% | 13 |
| 9 | CA 2 ANTAGONIST | 4 | 75% | 0% | 3 |
| 10 | CALCIUM CALMODULIN BINDING | 4 | 56% | 0% | 5 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Nimodipine in animal model experiments of focal cerebral ischemia - A systematic review | 2001 | 106 | 41 | 68% |
| Calcium antagonists for ischemic stroke - A systematic review | 2001 | 81 | 37 | 68% |
| Calcium antagonists for acute ischemic stroke | 2012 | 2 | 40 | 63% |
| NIMODIPINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, AND THERAPEUTIC EFFICACY IN CEREBRAL-DISORDERS | 1992 | 53 | 89 | 54% |
| Ca2+ channel antagonists and neuroprotection from cerebral ischemia | 1998 | 81 | 98 | 28% |
| Cognitive Impairment and Cerebral Hypoperfusion in a CADASIL Patient Improved During Administration of Lomerizine | 2009 | 3 | 13 | 46% |
| PHARMACOLOGICAL BASIS FOR THE USE OF NIMODIPINE IN CENTRAL NERVOUS-SYSTEM DISORDERS | 1989 | 241 | 42 | 45% |
| NIMODIPINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN CEREBROVASCULAR-DISEASE | 1989 | 163 | 90 | 53% |
| THE CURRENT STATUS OF NEURONAL PROTECTIVE THERAPY - WHY HAVE ALL NEURONAL PROTECTIVE DRUGS WORKED IN ANIMALS BUT NONE SO FAR IN STROKE PATIENTS | 1994 | 60 | 22 | 32% |
| Calcium antagonists: Their role in neuroprotection | 1997 | 19 | 53 | 42% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HUI MED MODERNIZAT | 1 | 50% | 0.1% | 1 |
| 2 | NANJING COMMAND PEOPLES LIBERAT ARMY | 1 | 50% | 0.1% | 1 |
| 3 | PHARMACOL CEREBROVASC DISORDERS | 1 | 50% | 0.1% | 1 |
| 4 | PHYSIOL PETTENKOFERSTR 12 | 1 | 50% | 0.1% | 1 |
| 5 | REGULAT NEURON FUNCT | 0 | 33% | 0.1% | 1 |
| 6 | NANJING GEN HOSP PLA | 0 | 25% | 0.1% | 1 |
| 7 | PSYCHIAT CLIN POLICLIN | 0 | 25% | 0.1% | 1 |
| 8 | PHARMACEUT SCI BIOPHARM | 0 | 20% | 0.1% | 1 |
| 9 | NEUROPSYCHOACT DRUGS | 0 | 17% | 0.1% | 1 |
| 10 | PSYCH | 0 | 14% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000161243 | VINCONATE//DELAYED NEURONAL DEATH//GERBIL |
| 2 | 0.0000155088 | META LEVEL INFERENCE//P TOLUENE SULFONYL CHLORIDE//CEREBRAL VASODILATOR |
| 3 | 0.0000125429 | STROKE TRIALS UNIT//INDUCED HYPERTENSION//BLOOD PRESSURE MANAGEMENT |
| 4 | 0.0000123616 | LAZAROIDS//LAZAROID//U74006F |
| 5 | 0.0000115093 | ANOXIA AGLYCEMIA//NA CA2 CHANNEL BLOCKER//NS 7 |
| 6 | 0.0000102823 | SR 33557//SR33805//H 3PN200 110 |
| 7 | 0.0000101583 | EXPERIMENTAL THROMBOEMBOLISM//MIDDLE CEREBRAL ARTERY OCCLUSION//INTRALUMINAL SUTURE |
| 8 | 0.0000099673 | POSTSTROKE HYPERGLYCEMIA//QUEENS NEUROSCI//STUDY NEUROL DIS |
| 9 | 0.0000093061 | DOTARIZINE//DRUG INDUCED PARKINSONISM//CINNARIZINE |
| 10 | 0.0000091781 | EXPTL EPILEPSIEFOR//EXPERIMENTAL EPILEPSY MODELS//MODEL NERVOUS SYSTEM |